Skip to Content

Join the 'Oseltamivir' group to help and get support from people like you.

Oseltamivir News

Almost Half of American Adults With HIV Don't Take Meds: Report

Posted 24 Sep 2015 by

THURSDAY, Sept. 24, 2015 – Almost half of American adults infected with HIV don't take medications that can prevent them from developing AIDS, a new government report shows. The statistics, based on data gathered from 2007 to 2012, are a few years out of date, so it's not clear whether the situation has changed. Still, the report – an analysis of people aged 18 to 59 – suggests a widespread lack of recommended care. "Based on what we know nowadays, everyone who's HIV-positive should be on therapy," said Dr. Carlos del Rio, co-director of the Center for AIDS Research at Emory University, in Atlanta. "This highlights the challenges we have ahead because we have such an unequal epidemic." The report, authored by Dr. Joseph Woodring of the U.S. National Center for Health Statistics, estimated the prevalence of HIV infection based on a survey of more than 10,000 people. The survey found ... Read more

Related support groups: HIV Infection, Tamiflu, Sovaldi, Incivek, Pre-Exposure Prophylaxis, Baraclude, Victrelis, Tenofovir, Kaletra, Sofosbuvir, Oseltamivir, Norvir, Viread, Entecavir, Telaprevir, Lamivudine, Boceprevir, Efavirenz, Reyataz, Nevirapine

Early Treatment With Flu Antivirals May Shorten Seniors' Hospital Stay

Posted 3 Sep 2015 by

THURSDAY, Sept. 3, 2015 – Early antiviral treatment for seniors with severe cases of the flu may shorten their hospital stay and reduce the need for extended care after discharge, a new government study finds. "Flu can be extremely serious in older people, leading to hospitalization and, in some cases, long-term disability. This important study shows that people 65 and older should seek medical care early when they develop flu symptoms," Dr. Dan Jernigan, director of the U.S. Centers for Disease Control and Prevention's influenza division, said in an agency news release on the study. People aged 65 and older are at high risk for serious flu complications and should be treated with antiviral drugs as early as possible, according to the CDC. In the study, CDC researchers analyzed data gathered from more than 250 hospitals in 13 states during three consecutive flu seasons (2010-2013), to ... Read more

Related support groups: Influenza, Tamiflu, Oseltamivir, Zanamivir, Relenza, Rapivab, Peramivir

Many U.S. AIDS Patients Still Die When 'Opportunistic' Infections Strike

Posted 1 Jul 2015 by

WEDNESDAY, July 1, 2015 – Even after the advent of powerful medications for suppressing HIV, a new study finds that more than one-third of people in San Francisco who were diagnosed with an AIDS-related infection died within five years. "The main cause of mortality arises from people stopping treatment entirely," said Dr. Robert Grant, a professor at the University of California, San Francisco, who reviewed the findings but was not involved in the research. When HIV treatment lapses, so-called "opportunistic" infections and illnesses can arise, posing a real threat to patients' health, he explained. The bottom line, according to Grant, is that there is still "a long way to go" in prolonging the lives of Americans with HIV/AIDS. The new study was led by Dr. Sandra Schwarcz, associate professor of epidemiology and biostatistics at the University of California, San Francisco. She and her ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Tamiflu, Sovaldi, Incivek, Pre-Exposure Prophylaxis, Truvada, Baraclude, Stribild, Victrelis, Complera, Mycobacterium avium-intracellulare, Triumeq, Tenofovir, Mycobacterium avium-intracellulare - Treatment, Sofosbuvir, Kaletra, Oseltamivir, Norvir

Global Trial Finds HIV Drugs Should Be Taken Right After Diagnosis

Posted 28 May 2015 by

WEDNESDAY, May 27, 2015 – People with HIV should start taking medications to battle the virus that causes AIDS as soon as they're diagnosed, a new international study finds. Scientists involved in the trial were so impressed by the health benefits of early use of HIV drugs that they shut the study down early so they could offer the medications to all participants. The findings could alter World Health Organization guidelines about the best way to treat people with HIV, experts said. Currently, WHO recommends that HIV patients not start treatment until their immune system show signs of weakening. "We now have clear-cut proof that it is of significantly greater health benefit to an HIV-infected person to start antiretroviral therapy sooner rather than later," Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said in a statement. "Moreover, ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Tamiflu, Incivek, Truvada, Baraclude, Stribild, Complera, Victrelis, Triumeq, Tenofovir, Oseltamivir, Kaletra, Viread, Entecavir, Norvir, Telaprevir, Lamivudine, Nevirapine

Tamiflu Cuts One Day Off Average Flu Bout, Study Finds

Posted 30 Jan 2015 by

THURSDAY, Jan. 29, 2015 – A review of the data suggests that the antiviral drug Tamiflu shortens the length of flu symptoms by about a day, and reduces the risk of flu-related complications such as pneumonia. The findings come from an analysis of nine published and unpublished randomized clinical trials of Tamiflu (oseltamivir) in adults. The data was provided to the researchers by Tamiflu's maker, Roche. The studies compared the effectiveness of the licensed 75-milligram dose of Tamiflu against a placebo in more than 4,300 adults who had the flu between 1997 and 2001. In patients with laboratory-confirmed flu, Tamiflu shorted the length of flu symptoms by 21 percent compared with the placebo, shortening the average flu bout from about five days to four. Compared to flu sufferers who took the placebo, patients who took Tamiflu also had a 44 percent lower risk of lower respiratory ... Read more

Related support groups: Influenza, Tamiflu, Oseltamivir

Flu Shot May Offer Less Protection This Winter: CDC

Posted 4 Dec 2014 by

THURSDAY, Dec. 4, 2014 – This flu season looks like it could be worse than usual, due to an aggressive strain of influenza virus that might flout the protection provided by this year's vaccine, U.S. health officials warned Thursday. A strain of influenza called H3N2 appears to be circulating most widely this season, and in the past death rates from H3N2 have been more than double that of other flu strains, according to officials from the U.S. Centers for Disease Control and Prevention. "We know that in seasons when H3 viruses predominate, we tend to have seasons that are worse flu years, with more hospitalizations from flu and more deaths from influenza," CDC Director Dr. Tom Frieden said during a news briefing. To make matters more difficult, about half of the H3N2 viruses detected by CDC researchers so far appear to have mutated, and have genetically "drifted" away from the virus ... Read more

Related support groups: Influenza, Tamiflu, Oseltamivir, FluLaval, Afluria, FluMist, Fluzone, Flucelvax, Influenza Virus Vaccine, Inactivated, Relenza, Zanamivir, Fluogen, Fluvirin, Fluzone PFS, Fluarix, Fluzone SV, Agriflu, Flushield, Influenza Virus Vaccine, Live, Trivalent, Fluzone Preservative-Free

Study Finds Many Flu Patients Not Treated Appropriately

Posted 18 Jul 2014 by

THURSDAY, July 17, 2014 – Antiviral drugs aren't prescribed often enough for patients at high risk for flu complications, while too many of them receive unneeded antibiotics, a new study says. The findings show that doctors require more training about the proper use of antiviral and antibiotic drugs in treating flu patients, the researchers said. Unnecessary use of antibiotics contributes to the development of antibiotic resistance. "Our results suggest that during 2012-13, antiviral medications were underprescribed and antibiotics may have been inappropriately prescribed to a large proportion of outpatients with influenza," wrote Dr. Fiona Havers and colleagues from the U.S. Centers for Disease Control Prevention and several other institutions. The researchers analyzed data from about 6,800 patients with flu symptoms seen at five outpatient care centers in Michigan, Pennsylvania, ... Read more

Related support groups: Amoxicillin, Influenza, Azithromycin, Augmentin, Zithromax, Tamiflu, Amoxil, Amoxicillin/Clavulanate, Zithromax Z-Pak, Z-Pak, Oseltamivir, Amoxil Pediatric Drops, Amoclan, Augmentin XR, Azithromycin Dose Pack, Zithromax TRI-PAK, Zithromax IV, Trimox, Augmentin ES-600, Biomox

Report Questions Effectiveness of Flu Meds

Posted 13 Apr 2014 by

THURSDAY, April 10, 2014 – No evidence exists to show that anti-flu medicines stockpiled by countries around the world protect people from the spread of flu or reduce related hospitalizations and complications, a new analysis contends. The report from the nonprofit Cochrane Collaboration urges world leaders who spend countless dollars on medications like Tamiflu and Relenza for use in an influenza pandemic to reconsider this practice. The findings, published April 10 in the BMJ, come from an analysis of internal reports of 20 Tamiflu (oseltamivir) and 26 Relenza (zanamivir) trials that involved more than 24,000 people. Taking one of these drugs may reduce flu symptoms in adults by less than a day compared to taking an inactive placebo, the researchers found. However, they said claims that the drugs – known as neuraminidase inhibitors – curb flu transmission or reduce complications ... Read more

Related support groups: Influenza, Tamiflu, Oseltamivir, Zanamivir, Relenza

Tamiflu Saved Lives During Swine Flu Pandemic, Study Confirms

Posted 18 Mar 2014 by

TUESDAY, March 18, 2014 – The antiviral drug Tamiflu reduced the risk of death by 25 percent among adults hospitalized during the 2009 H1N1 swine flu pandemic, according to a new review. Also, antiviral treatment within 48 hours of developing flu symptoms halved the risk of death compared with starting treatment later or receiving no treatment, according to the study, which was published March 18 in the journal The Lancet Respiratory Medicine. The risk of death rose by about 20 percent for every 24 hours that treatment was delayed after 48 hours since the start of symptoms, the researchers also found. "As expected, early treatment seems to be optimal, and treatment shouldn't be delayed by even one day to wait for diagnostic test results," Alicia Fry, of the U.S. Centers for Disease Control and Prevention, wrote in an accompanying journal editorial. "However, if the patient presents for ... Read more

Related support groups: Tamiflu, Swine Influenza, Oseltamivir

Liquid Tamiflu for Kids in Short Supply

Posted 8 Jan 2014 by

WEDNESDAY, Jan. 8, 2014 – Manufacturing problems have created a shortage of the liquid form of Tamiflu, which is designed for young children who can't swallow capsules, U.S. health officials announced Wednesday. The drug's maker, Genentech, has fallen behind in production of this version of the flu medication, according to the U.S. Food and Drug Administration. However, the shortage doesn't include the capsule form of Tamiflu, which remains in good supply, said Dr. Michael Jhung, a medical officer with the U.S. Centers for Disease Control and Prevention's Influenza Division. Flu vaccines also remain widely available and unaffected by shortages, FDA spokesman Eric Pahon said. The CDC recommends vaccination for everyone older than 6 months of age as the best way to try to ward off the flu. A shortage of liquid Tamiflu could cause some children to be sick with the flu longer, Jhung said. ... Read more

Related support groups: Tamiflu, Oseltamivir

Kids Hospitalized for Flu Need Antiviral Meds Right Away: Study

Posted 25 Nov 2013 by

MONDAY, Nov. 25, 2013 – Kids near death because of severe flu infection have a better chance of survival if they are given antiviral medications early in their treatment, researchers say. Children treated with antiviral drugs called neuraminidase inhibitors (NAIs) within the first 48 hours of serious flu symptoms developing are significantly more likely to survive, according to a study published online Nov. 25 in the journal Pediatrics. "The benefit was more apparent for the most severely ill children, who required a ventilator to help with breathing," said co-author Dr. Janice Louie, chief of the influenza and respiratory diseases section at the California Department of Public Health's Center for Infectious Diseases. In children rendered critically ill by the flu, treatment with NAIs reduced their risk of dying by 64 percent, the study found. Researchers found that in recent years, ... Read more

Related support groups: Influenza, Tamiflu, Oseltamivir, Zanamivir, Relenza

Doubling Tamiflu Dose for Severe Flu Doesn't Help: Study

Posted 30 May 2013 by

THURSDAY, May 30 – People with a severe case of the flu don't benefit from taking double doses of the antiviral drug Tamiflu, according to a new study conducted in Southeast Asia. Tamiflu (oseltamivir) stocks could be conserved during pandemics if doctors prescribe only standard doses of this medication, World Health Organization experts suggested. The study involved 326 patients diagnosed with severe flu at 13 hospitals in Indonesia, Singapore, Thailand and Vietnam between April 2007 and February 2010. Most of the patients were children younger than 15, but some adults also were included. Health-care workers treated the patients with either a standard dose of Tamiflu (75 milligrams twice daily or the children's equivalent), or a double dose of the medication (150 milligrams twice daily or children's equivalent) over the course of five days. Patients' virus levels were measured through ... Read more

Related support groups: Influenza, Tamiflu, Oseltamivir

New China Bird Flu May Be Resistant to Tamiflu

Posted 28 May 2013 by

TUESDAY, May 28 – Chinese scientists say they've identified the first cases of resistance to the flu drug Tamiflu in a person infected with the emerging H7N9 avian flu virus. According to BBC News, there have been 131 confirmed cases in China of the new "bird" flu in humans so far, including 36 deaths. No new cases have been identified in over two weeks. According to the new report, published online May 28 in The Lancet, viral samples from three of 14 patients treated for H7N9 in a Shanghai hospital tested positive for resistance to Tamiflu (oseltamivir). These three patients were also the most severely ill – two died, and the third was still on mechanical ventilation at the time the Lancet paper was published. "The apparent ease with which antiviral resistance emerges in A/H7N9 [flu] viruses is concerning; it needs to be closely monitored and considered in future pandemic response ... Read more

Related support groups: Tamiflu, Oseltamivir, Avian Influenza

'Spot' Shortages of Flu Vaccine, Tamiflu Reported, FDA Head Says

Posted 15 Jan 2013 by

TUESDAY, Jan. 15 – Sporadic shortages of both the flu vaccine and the flu treatment Tamiflu are being reported, as this year's intense flu season continues, according to a top U.S. health official. "We have received reports that some consumers have found spot shortages of the vaccine," Dr. Margaret Hamburg, commissioner of the U.S. Food and Drug Administration, said Monday on her blog on the agency's website. Hamburg said that the agency is "monitoring this situation and will update you at our website and at" So far, more than 128 million doses of flu vaccine have been distributed, Hamburg said, but not all the doses have been administered to people yet. She said that people who already have the flu may also be experiencing local shortages of Tamiflu, a drug that can help treat influenza. "We do anticipate intermittent, temporary shortages of the oral suspension form of ... Read more

Related support groups: Influenza, Tamiflu, Oseltamivir, FluLaval, Afluria, Fluzone, Influenza Prophylaxis, Flucelvax, Influenza Virus Vaccine, Inactivated, Flushield, Fluzone Preservative-Free, Fluarix, Fluzone WV, Fluogen, Fluvirin, Fluzone PFS, Agriflu, Fluzone SV

FDA Expands Tamiflu's Use to Treat Children Younger Than One Year

Posted 21 Dec 2012 by

December 21, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Tamiflu (oseltamivir) to treat children as young as 2 weeks old who have shown symptoms of flu for no longer than two days. The drug is not approved to prevent flu infection in this population. In addition, the safety and efficacy of Tamiflu to treat flu infection has not been established in children younger than 2 weeks old. Tamiflu was approved in 1999 to treat adults infected with flu who have shown symptoms for no longer than two days. It has since been approved to treat flu in children ages 1 year and older who have shown symptoms of flu for no longer than two days, and to prevent flu in adults and children ages 1 year and older. Although there is a fixed dosing regimen for patients 1 year and older according to weight categories, the dosing for children younger than 1 year must be ... Read more

Related support groups: Influenza, Tamiflu, Swine Influenza, Oseltamivir, Swine Flu, Influenza Prophylaxis, Flu, Flu Prevention

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Swine Influenza, Influenza, Avian Influenza, Influenza Prophylaxis

Related Drug Support Groups


Oseltamivir Patient Information at